Avadel Pharmaceuticals Plc financial data

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland
Fiscal year end
December 31
Former names
FLAMEL TECHNOLOGIES SA (to 12/30/2016)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % +42.9%
Quick Ratio 22.3 %
Debt-to-equity 100 % -87%
Return On Equity -123 % +84.7%
Return On Assets -61.3 % +33.5%
Operating Margin -104 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.3M shares +7.72%
Common Stock, Shares, Outstanding 96.2M shares +7.71%
Entity Public Float 1.46B USD +926%
Common Stock, Value, Issued 961K USD +7.62%
Weighted Average Number of Shares Outstanding, Basic 96.2M shares +24.5%
Weighted Average Number of Shares Outstanding, Diluted 96.2M shares +24.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 95.1M USD +2674%
Research and Development Expense 12.3M USD -28.4%
Costs and Expenses 144M USD +46.3%
Operating Income (Loss) -98.8M USD +16.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -107M USD +25.5%
Income Tax Expense (Benefit) -427K USD -27.5%
Net Income (Loss) Attributable to Parent -106M USD +25.6%
Earnings Per Share, Basic -1.13 USD/shares +45.7%
Earnings Per Share, Diluted -1.13 USD/shares +45.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.8M USD -42.3%
Marketable Securities, Current 42.5M USD -61.5%
Accounts Receivable, after Allowance for Credit Loss, Current 33.4M USD +1780%
Inventory, Net 13.3M USD +825%
Other Assets, Current 672K USD -10%
Assets, Current 126M USD -26.5%
Property, Plant and Equipment, Net 484K USD -32.3%
Operating Lease, Right-of-Use Asset 2.15M USD +74.4%
Goodwill 16.8M USD 0%
Other Assets, Noncurrent 12M USD +14%
Assets 158M USD -21.6%
Accounts Payable, Current 9.79M USD -16.9%
Accrued Liabilities, Current 33.7M USD +91.7%
Liabilities, Current 44.6M USD -13.4%
Operating Lease, Liability, Noncurrent 1.31M USD +167%
Other Liabilities, Noncurrent 5.82M USD +0.47%
Liabilities 87.2M USD +51%
Accumulated Other Comprehensive Income (Loss), Net of Tax -24.2M USD +6.66%
Retained Earnings (Accumulated Deficit) -787M USD -15.6%
Stockholders' Equity Attributable to Parent 70.3M USD -50.9%
Liabilities and Equity 158M USD -21.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD +1.75%
Net Cash Provided by (Used in) Financing Activities 13.2M USD -61.7%
Net Cash Provided by (Used in) Investing Activities 21.4M USD +322%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.2M shares +7.71%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.63M USD -50.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.8M USD -42.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 730K USD -76.1%
Deferred Tax Assets, Valuation Allowance 96.4M USD +35.2%
Deferred Tax Assets, Gross 96.4M USD +35%
Operating Lease, Liability 2.62M USD +50.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -104M USD +26.6%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD +66.1%
Operating Lease, Liability, Current 866K USD +10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 683K USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.09M USD +7.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +60%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 420K USD +352%
Lessee, Operating Lease, Liability, to be Paid, Year Three 477K USD +132%
Deferred Tax Assets, Operating Loss Carryforwards 71.1M USD +33.1%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 3.04M USD -3.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 477K USD
Preferred Stock, Shares Outstanding 0 shares -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%